Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of flexible doses of milnacipran versus venlafaxine in outpatients with major depressive disorder
2006-003658-47Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in major depressive disorder (MDD) comparing Milnacipran arm with Venlafaxine arm (2 arms). Primary endpoints: Primary efficacy criterion and Safety assessment. Started Aug 2006; status: completed.
02
Drugs
milnacipranvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-003658-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003658-47.